Brief: Palvella Therapeutics Reports Third Quarter 2025 Financial Results And Provides Corporate Update
11/11/2025 16:16
Nov 11 (Reuters) - Palvella Therapeutics Inc PVLA.O: PALVELLA THERAPEUTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PALVELLA THERAPEUTICS INC: Q3 EPS $-1.03 Source text: ID:nGNX3DDvbc Further company coverage: PVLA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palvella Therapeutics
See all newsPalvella Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Palvella Therapeutics Q2 net loss widens on higher expenses
Brief: Palvella Therapeutics Announces New Data From The Phase 2 Toiva Trial Of Qtorin™ Rapamycin In Cutaneous Venous Malformations
Brief: Palvella Therapeutics Announces Uplisting To The Nasdaq Global Market
Palvella Therapeutics' Q1 net loss widens on higher costs